Glycaemic control in type 2 diabetes.
Campbell
Amaryllis
A
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D015190:Blood Glucose Self-Monitoring; D003510:Cyclohexanes / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000628:therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D000077715:Nateglinide; D010353:Patient Education as Topic; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D000077715:Nateglinide; D010649:Phenylalanine; D008687:Metformin